Gene and Protein Expression of P-Glycoprotein, MRP1, MRP2, and CYP3A4 in the Small and Large Human Intestine
- 31 January 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 4 (2) , 252-257
- https://doi.org/10.1021/mp0600687
Abstract
The cytochrome P450 3A4 enzyme and the ABC-transporters may affect the first-pass extraction and bioavailability of drugs and metabolites. Conflicting reports can be found in the literature on the expression levels of efflux transporters in human intestine and how they vary along the intestine. The relative levels of mRNA and protein of CYP3A4 and the ABC tranporters Pgp (ABCB1), MRP1 (ABCC1), and MRP2 (ABCC2) were determined using RT-PCR and Western blot for human intestinal tissues (n = 14) from jejunum, ileum and colon. The expression of mRNA for CYP3A4, Pgp, and MRP2 was highest in jejunum and decreased toward more distal regions, whereas MRP1 was equally distributed in all intestinal regions. For CYP3A4, a more significant correlation could be established between mRNA and protein expression than for the ABC transporters. The samples showed considerable interindividual variability, especially at the protein level. The apically located Pgp and MRP2 showed a similar expression pattern along the human intestine as for CYP3A4. The gene expression of MRP1 exhibited a more uniform distribution. Keywords: P-glycoprotein; CYP3A4; MRP; human; intestine; RT-PCR; Western blotKeywords
This publication has 21 references indexed in Scilit:
- MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACTDrug Metabolism and Disposition, 2005
- Mammalian ABC Transporters in Health and DiseaseAnnual Review of Biochemistry, 2002
- Pxr, car and drug metabolismNature Reviews Drug Discovery, 2002
- Region-Dependent Modulation of Intestinal Permeability by Drug Efflux Transporters: In Vitro Studies in mdr1a(−/−) Mouse IntestineThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosisBritish Journal of Clinical Pharmacology, 2001
- The role of intestinal P-glycoprotein in the interaction of digoxin and rifampinJournal of Clinical Investigation, 1999
- Role of P-Glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics†Journal of Pharmaceutical Sciences, 1998
- The barrier function of CYP3A4 and P-glycoprotein in the small bowelAdvanced Drug Delivery Reviews, 1997
- Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRPCancer Letters, 1997
- Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlationBritish Journal of Pharmacology, 1996